Benzeni

2-Amino-6-chlorobenzoic acid is a fine chemical that is used as a reagent or speciality chemical.

2-Chloro-4-trifluoromethylbenzoic acid is a chemical compound with the formula CHClFO. It can be obtained by deprotonation of 2,4,6-trichlorobenzoic acid with butyllithium and subsequent reaction with chlorotrifluoromethane. The product has two regioisomers, one in which the chlorine atom is attached to the para position on the benzene ring and the other in which it is attached to the ortho position. Substituents such as alkyl groups or lithium reagents can affect both reactivity and selectivity. The halogen substituent can also be replaced by other functional groups to make derivatives of this compound.

3-Bromo-5-hydroxybenzoic acid is a metabolite of 3,5-dihydroxybenzoic acid (DHB) in the metabolism of benzoic acid. It has been shown to be an antibacterial agent and has been used to treat metabolic disorders in hamsters. Symptoms of 3-bromo-5-hydroxybenzoic acid include dyslipidemia, which can lead to metabolic disorders such as diabetes mellitus and atherosclerosis. The compound may also have a role in tuberculosis and cancer due to its ability to induce apoptosis.

Synthetic building block

Methyl 4-aminobenzoate is a chemical compound that is used as a fluorescence probe in the study of DNA replication. It can be used to detect the presence of viral RNA in cell culture, and has been shown to inhibit the replication of bacterial RNA. Methyl 4-aminobenzoate binds to guanine residues in DNA and forms an alkyl bond with them. This prevents the binding of other amino acids, which are essential for DNA replication. Methyl 4-aminobenzoate has also been shown to have pharmacokinetic properties that make it useful for intravenous administration and oral administration.

3-Methyl-4-nitrobenzoic acid is a white solid that can be synthesized by heating 2,4-dichlorobenzoic acid with potassium dichromate in the presence of nitrogen. It has been shown to be effective against Candida glabrata strains and other bacteria. 3-Methyl-4-nitrobenzoic acid is soluble in water and other polar solvents, such as acetic acid or sodium carbonate, but insoluble in nonpolar solvents such as hexane or ether. The reaction mechanism for this compound is not yet known. It has been found to have a phase equilibrium between its solid and liquid forms at room temperature. Solubility data for this compound are available from experimental measurements.

4-Benzyloxybenzoic acid is a carboxylic acid that is structurally related to adenosine. It has been shown to bind to the group P2 adenosine receptor, which may be involved in the regulation of locomotor activity and photophysical properties. This compound also inhibits fatty acid biosynthesis and has inhibitory effects on nerve injury, amide formation, and benzoate degradation. It has been reported that 4-Benzyloxybenzoic acid binds to metal ions such as cobalt and manganese, which may be important for its antimycobacterial activity.

5-Nitrosalicylic acid is an ethylene diamine derivative that is used in organic synthesis. It reacts with nitrogen atoms to form stable complexes. 5-Nitrosalicylic acid reacts with hydrogen and forms a protonated acid complex, which is more soluble in water than the molecule itself. The protonated acid complex can be used for the production of glycan, which are biomolecules that play a major role in the human body. Synchronous fluorescence spectroscopy has shown that 5-nitrosalicylic acid reacts with glycan by hydrogen bonding interactions and stabilizing nitro groups.

2,4-Dihydroxy-3-methylbenzoic acid (2,4-DMB) is a potent compound that has been shown to have chemotherapeutic properties. It is a DNA repair agent that also inhibits the activity of topoisomerase II and DNA polymerase III. 2,4-DMB can be used in the treatment of radiation and ionizing radiation induced cancers. The pharmacophore of 2,4-DMB has been identified as being composed of three hydrophobic regions and one hydrophilic region. This pharmacophore has been used to design other potent compounds with similar activity against cancer cells.

Please enquire for more information about 3-Chloro-5-hydroxybenzoic acid ethyl ester including the price, delivery time and more detailed product information at the technical inquiry form on this page

Glyceryl-4-aminobenzoate monomer is a fine chemical that is an important building block in the synthesis of a variety of complex compounds. It has been used as a reagent and intermediate in research and development of pharmaceuticals and agrochemicals. Glyceryl-4-aminobenzoate monomer is a versatile building block, which can be used to form polymers, coatings, adhesives, elastomers, polyurethanes, and more. The compound also has been shown to have anticancer activity against human breast cancer cells.

3-(Trifluoromethyl)phenylacetone is a chiral iminium-type organocatalyst that is used in asymmetric organic reactions. This compound has been shown to be effective for the synthesis of chiral amines and hydroxyl groups, as well as biotransformations. 3-(Trifluoromethyl)phenylacetone binds to substrates through hydrogen bonding, steric interactions, and electrostatic interactions. It also has a high affinity for hydroxides and isosteres. 3-(Trifluoromethyl)phenylacetone can be used as an alternative to L-proline in certain biotransformations because it binds more tightly to the enzyme than L-proline does.

5-Bromo-3,4-dihydroxybenzaldehyde (5BDBA) is a chemical compound that can be used as a reactive dye and photochemical crosslinker in the preparation of polymers. 5BDBA has been shown to have chemoattractant properties for immune cells, such as activated T lymphocytes and neutrophils. It also has been shown to have an effect on β-cells in the pancreas and skin cells. This compound has been found to activate the nuclear factor kappa-light-chain enhancer (NFκB), which leads to increased expression of chemoattractant protein (MCP). In 3T3-L1 preadipocytes, 5BDBA has been shown to induce accumulation of fatty acids by activating peroxisome proliferator activator receptor gamma.

2-(4'-Chlorobenzoyl)benzoic acid (2-CBA) is a sulfa drug that inhibits bacterial growth by blocking the synthesis of folic acid. It is also known to be luminescent and can be used in techniques such as luminescent probes. 2-CBA has antibacterial activity and can inhibit bacterial growth in a chromatographic method. 2-CBA is chemically stable and has been shown to have antibacterial properties against gram-positive bacteria, including Bacillus subtilis and Staphylococcus aureus. 2-CBA also has the ability to react with phthalazinone, an inhibitor of glutamine synthetase, which is involved in the production of ATP from ADP. This reaction results in the formation of an unstable intermediate which decomposes into CO2 and benzoic acid.

4-Amino-3-hydroxybenzoic acid is a small molecule that has been shown to inhibit the activity of epidermal growth factor receptor (EGFR) and human epidermal growth factor (HER2). It is also an inhibitor of cytochrome P450 enzymes, which are involved in the metabolism of drugs. 4-Amino-3-hydroxybenzoic acid is used in vitro as an antifungal agent for Candida albicans and other pathogenic fungi. This drug inhibits the growth of cancer cells by binding to specific cell surface receptors, causing them to detach from their surroundings and die. 4-Amino-3-hydroxybenzoic acid may have potential as a drug for treating metastatic colorectal cancer. The mechanism of action is not yet fully understood but it may be related to the inhibition of intermolecular hydrogen bonding and water permeability.

Atranol is a phenolic compound that is found in plants such as the leaves of the white willow tree. It has been shown to have anti-inflammatory properties and is being researched for its potential use in treatment of inflammatory bowel disease. Atranol has been shown to inhibit the production of inflammatory cytokines such as tumor necrosis factor-α (TNF-α) and interleukin-1β (IL-1β), which are key mediators of inflammation, by inhibiting NFκB activation. The reaction mechanism for atranol's inhibition of IL-1β production involves atranol binding with the cystein residue on IκB kinase β, which prevents phosphorylation and thus activation.

3,5-Dinitrosalicylaldehyde is an oxidizing agent that is used in organic chemistry to produce aldehydes or carboxylic acids. It reacts with the amino groups of lysine residues and converts them to nitro groups. 3,5-Dinitrosalicylaldehyde is also used as a reagent in the determination of the number of lysine residues in proteins by titration with hydrochloric acid. The reaction mechanism of 3,5-dinitrosalicylaldehyde involves formation of an electron deficient intermediate that oxidizes chloride ions to form water molecules and chloride radicals. These intermediates react with nitro groups on lysine residues, resulting in nitro compounds. Crystallography studies have shown that the molecular structure of 3,5-dinitrosalicylaldehyde has two nitro groups and one hydroxyl group.

Intermediate in organic synthesis

3,4-Dibenzyloxybenzaldehyde is a chemical compound with the formula ClCH=C(O)CHO. This compound is an intermediate in the synthesis of the cancer drug daunorubicin. 3,4-Dibenzyloxybenzaldehyde has been shown to induce apoptosis in human ovary cells and has been detected in urine samples from patients undergoing chemotherapy for ovarian cancer. 3,4-Dibenzyloxybenzaldehyde also inhibits the production of flavonoids and has been shown to inhibit rat striatal membranes and rat atria.